Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × cemiplimab × Clear all

Sponsor

Conditions

Recurrence 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Cutaneous Squamous Cell Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Advanced Non-Small Cell Lung Carcinoma 1 Adenocarcinoma 1

Interventions

Oxaliplatin 46 Fluorouracil 43 Leucovorin 40 Capecitabine 36 Bevacizumab 28 Irinotecan 27 Radiotherapy 22 Cetuximab 21 Panitumumab 12 Radiation 11 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 7 Radiotherapy, Intensity-Modulated 6 aflibercept 5 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Chemotherapy, Adjuvant 5 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 XELOX 3 Ramucirumab 3 Neoadjuvant Therapy 3 Fluorodeoxyglucose F18 3 Erlotinib Hydrochloride 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 veliparib 2 trifluridine tipiracil drug combination 2 regorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡